ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Coccidiosis Vaccines Market Research Report 2024
Published Date: January 2025
|
Report Code: QYRE-Auto-26H18155
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Coccidiosis Vaccines Market Research Report 2024
BUY CHAPTERS

Global Coccidiosis Vaccines Market Research Report 2024

Code: QYRE-Auto-26H18155
Report
January 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
MSD Animal Health
Boehringer Ingelheim
Hipra
Bioproperties Pty Ltd
Huvepharma
Nisseiken Co., Ltd.
Biopharm GmbH
Ceva Santé Animale
Vaxxinova
Foshan Standard Biotech
Qilu Qingda Bio-Pharmaceutical
Skystar Bio-Pharm
Hlinte
Guangdong Winsun Bio Pharmaceutical

Coccidiosis Vaccines Market Size

The global market for Coccidiosis Vaccines was valued at US$ 161 million in the year 2023 and is projected to reach a revised size of US$ 224 million by 2030, growing at a CAGR of 4.8% during the forecast period.

Coccidiosis Vaccines Market

Coccidiosis Vaccines Market

Coccidiosis vaccines are biological preparations aimed at preventing coccidiosis, a parasitic disease primarily affecting livestock and poultry, particularly chickens. This disease is caused by various species of protozoan parasites from the genus Eimeria, which infect the intestinal lining, leading to symptoms such as diarrhea, weight loss, and decreased feed efficiency. Coccidiosis vaccines typically contain live attenuated or killed strains of Eimeria parasites, which stimulate the host's immune system to develop protective immunity against future infections.
Coccidiosis is one of the most common parasitic diseases in the poultry industry, primarily caused by Eimeria species. This disease poses a significant threat to poultry health and can lead to a notable decrease in production performance, even resulting in death. Traditionally, the poultry industry has relied on anticoccidial drugs for prevention and treatment, but with the increasing problem of drug resistance, the over-reliance on anticoccidial medications is gradually being challenged. As a result, coccidiosis vaccines have become an important alternative to drug treatments.
The vaccine works by simulating a coccidial infection, triggering an immune response in the poultry's system, thereby enhancing immunity against future infections. Unlike drug treatments, vaccines effectively reduce the dependence on antibiotics, help curb the development of resistance, and promote a more sustainable and environmentally friendly poultry industry. The use of coccidiosis vaccines not only reduces the incidence and mortality of infections in poultry flocks but also improves production performance, such as weight gain in broilers and egg production in layers.
In recent years, with continuous innovation in vaccine technology, the types and effectiveness of coccidiosis vaccines have significantly improved. There are now many types of coccidiosis vaccines on the market, including attenuated live vaccines, inactivated vaccines, and recombinant and multivalent vaccines currently under development. These new-generation vaccines can target different species of Eimeria and offer stronger immune protection.
The demand for coccidiosis vaccines has gradually increased in recent years, mainly due to the rising consumer demand for antibiotic-free food and increased awareness of animal welfare and environmental protection. With the global trend towards larger-scale and more intensive poultry farming, the use of vaccines has become a key method for ensuring the health and sustainable development of poultry production.
Especially in the European and American markets, an increasing number of poultry farms are gradually eliminating anticoccidial drugs and turning to vaccines for prevention and treatment. This shift has contributed to the rapid growth of the vaccine market. In the Asia-Pacific region, particularly in countries such as China, India, and Southeast Asia, with the rapid development of poultry farming, the demand for coccidiosis vaccines is also increasing. More countries and regions are beginning to implement strict drug residue regulations, which has further driven the use of vaccines as an alternative solution.
This report aims to provide a comprehensive presentation of the global market for Coccidiosis Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coccidiosis Vaccines.
The Coccidiosis Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Coccidiosis Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Coccidiosis Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Coccidiosis Vaccines Market Report

Report Metric Details
Report Name Coccidiosis Vaccines Market
Accounted market size in year US$ 161 million
Forecasted market size in 2030 US$ 224 million
CAGR 4.8%
Base Year year
Forecasted years 2025 - 2030
by Type
by Application
  • Poultry
  • Rabbit
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company MSD Animal Health, Boehringer Ingelheim, HIPRA, Bioproperties, Huvepharma, Nisseiken, Biopharm, Ceva Santé Animale, Vaxxinova, Foshan Standard Biotech, Qilu Qingda Bio-Pharmaceutical, Skystar Bio-pharm, Hlinte, Guangdong Winsun Bio-pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Coccidiosis Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Coccidiosis Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Coccidiosis Vaccines Market growing?

Ans: The Coccidiosis Vaccines Market witnessing a CAGR of 4.8% during the forecast period 2025-2030.

What is the Coccidiosis Vaccines Market size in 2030?

Ans: The Coccidiosis Vaccines Market size in 2030 will be US$ 224 million.

Who are the main players in the Coccidiosis Vaccines Market report?

Ans: The main players in the Coccidiosis Vaccines Market are MSD Animal Health, Boehringer Ingelheim, HIPRA, Bioproperties, Huvepharma, Nisseiken, Biopharm, Ceva Santé Animale, Vaxxinova, Foshan Standard Biotech, Qilu Qingda Bio-Pharmaceutical, Skystar Bio-pharm, Hlinte, Guangdong Winsun Bio-pharmaceutical

What are the Application segmentation covered in the Coccidiosis Vaccines Market report?

Ans: The Applications covered in the Coccidiosis Vaccines Market report are Poultry, Rabbit, Others

What are the Type segmentation covered in the Coccidiosis Vaccines Market report?

Ans: The Types covered in the Coccidiosis Vaccines Market report are Attenuated Vaccines, Non-attenuated Vaccines

Recommended Reports

Poultry Vaccines

Animal Vaccines

Aquaculture Vaccines

1 Coccidiosis Vaccines Market Overview
1.1 Product Definition
1.2 Coccidiosis Vaccines by Type
1.2.1 Global Coccidiosis Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Attenuated Vaccines
1.2.3 Non-attenuated Vaccines
1.3 Coccidiosis Vaccines by Application
1.3.1 Global Coccidiosis Vaccines Market Value by Application (2024-2030)
1.3.2 Poultry
1.3.3 Rabbit
1.3.4 Others
1.4 Global Coccidiosis Vaccines Market Size Estimates and Forecasts
1.4.1 Global Coccidiosis Vaccines Revenue 2019-2030
1.4.2 Global Coccidiosis Vaccines Sales 2019-2030
1.4.3 Global Coccidiosis Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Coccidiosis Vaccines Market Competition by Manufacturers
2.1 Global Coccidiosis Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Coccidiosis Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Coccidiosis Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Coccidiosis Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Coccidiosis Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Coccidiosis Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Coccidiosis Vaccines, Date of Enter into This Industry
2.8 Global Coccidiosis Vaccines Market Competitive Situation and Trends
2.8.1 Global Coccidiosis Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Coccidiosis Vaccines Players Market Share by Revenue
2.8.3 Global Coccidiosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Coccidiosis Vaccines Market Scenario by Region
3.1 Global Coccidiosis Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Coccidiosis Vaccines Sales by Region: 2019-2030
3.2.1 Global Coccidiosis Vaccines Sales by Region: 2019-2024
3.2.2 Global Coccidiosis Vaccines Sales by Region: 2025-2030
3.3 Global Coccidiosis Vaccines Revenue by Region: 2019-2030
3.3.1 Global Coccidiosis Vaccines Revenue by Region: 2019-2024
3.3.2 Global Coccidiosis Vaccines Revenue by Region: 2025-2030
3.4 North America Coccidiosis Vaccines Market Facts & Figures by Country
3.4.1 North America Coccidiosis Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Coccidiosis Vaccines Sales by Country (2019-2030)
3.4.3 North America Coccidiosis Vaccines Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Coccidiosis Vaccines Market Facts & Figures by Country
3.5.1 Europe Coccidiosis Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Coccidiosis Vaccines Sales by Country (2019-2030)
3.5.3 Europe Coccidiosis Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Coccidiosis Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Coccidiosis Vaccines Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Coccidiosis Vaccines Sales by Region (2019-2030)
3.6.3 Asia Pacific Coccidiosis Vaccines Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Coccidiosis Vaccines Market Facts & Figures by Country
3.7.1 Latin America Coccidiosis Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Coccidiosis Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Coccidiosis Vaccines Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Coccidiosis Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Coccidiosis Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Coccidiosis Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Coccidiosis Vaccines Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Coccidiosis Vaccines Sales by Type (2019-2030)
4.1.1 Global Coccidiosis Vaccines Sales by Type (2019-2024)
4.1.2 Global Coccidiosis Vaccines Sales by Type (2025-2030)
4.1.3 Global Coccidiosis Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Coccidiosis Vaccines Revenue by Type (2019-2030)
4.2.1 Global Coccidiosis Vaccines Revenue by Type (2019-2024)
4.2.2 Global Coccidiosis Vaccines Revenue by Type (2025-2030)
4.2.3 Global Coccidiosis Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Coccidiosis Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Coccidiosis Vaccines Sales by Application (2019-2030)
5.1.1 Global Coccidiosis Vaccines Sales by Application (2019-2024)
5.1.2 Global Coccidiosis Vaccines Sales by Application (2025-2030)
5.1.3 Global Coccidiosis Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Coccidiosis Vaccines Revenue by Application (2019-2030)
5.2.1 Global Coccidiosis Vaccines Revenue by Application (2019-2024)
5.2.2 Global Coccidiosis Vaccines Revenue by Application (2025-2030)
5.2.3 Global Coccidiosis Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Coccidiosis Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 MSD Animal Health
6.1.1 MSD Animal Health Company Information
6.1.2 MSD Animal Health Description and Business Overview
6.1.3 MSD Animal Health Coccidiosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 MSD Animal Health Coccidiosis Vaccines Product Portfolio
6.1.5 MSD Animal Health Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Company Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Coccidiosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Coccidiosis Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 HIPRA
6.3.1 HIPRA Company Information
6.3.2 HIPRA Description and Business Overview
6.3.3 HIPRA Coccidiosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 HIPRA Coccidiosis Vaccines Product Portfolio
6.3.5 HIPRA Recent Developments/Updates
6.4 Bioproperties
6.4.1 Bioproperties Company Information
6.4.2 Bioproperties Description and Business Overview
6.4.3 Bioproperties Coccidiosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bioproperties Coccidiosis Vaccines Product Portfolio
6.4.5 Bioproperties Recent Developments/Updates
6.5 Huvepharma
6.5.1 Huvepharma Company Information
6.5.2 Huvepharma Description and Business Overview
6.5.3 Huvepharma Coccidiosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Huvepharma Coccidiosis Vaccines Product Portfolio
6.5.5 Huvepharma Recent Developments/Updates
6.6 Nisseiken
6.6.1 Nisseiken Company Information
6.6.2 Nisseiken Description and Business Overview
6.6.3 Nisseiken Coccidiosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nisseiken Coccidiosis Vaccines Product Portfolio
6.6.5 Nisseiken Recent Developments/Updates
6.7 Biopharm
6.7.1 Biopharm Company Information
6.7.2 Biopharm Description and Business Overview
6.7.3 Biopharm Coccidiosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Biopharm Coccidiosis Vaccines Product Portfolio
6.7.5 Biopharm Recent Developments/Updates
6.8 Ceva Santé Animale
6.8.1 Ceva Santé Animale Company Information
6.8.2 Ceva Santé Animale Description and Business Overview
6.8.3 Ceva Santé Animale Coccidiosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ceva Santé Animale Coccidiosis Vaccines Product Portfolio
6.8.5 Ceva Santé Animale Recent Developments/Updates
6.9 Vaxxinova
6.9.1 Vaxxinova Company Information
6.9.2 Vaxxinova Description and Business Overview
6.9.3 Vaxxinova Coccidiosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Vaxxinova Coccidiosis Vaccines Product Portfolio
6.9.5 Vaxxinova Recent Developments/Updates
6.10 Foshan Standard Biotech
6.10.1 Foshan Standard Biotech Company Information
6.10.2 Foshan Standard Biotech Description and Business Overview
6.10.3 Foshan Standard Biotech Coccidiosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Foshan Standard Biotech Coccidiosis Vaccines Product Portfolio
6.10.5 Foshan Standard Biotech Recent Developments/Updates
6.11 Qilu Qingda Bio-Pharmaceutical
6.11.1 Qilu Qingda Bio-Pharmaceutical Company Information
6.11.2 Qilu Qingda Bio-Pharmaceutical Description and Business Overview
6.11.3 Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Product Portfolio
6.11.5 Qilu Qingda Bio-Pharmaceutical Recent Developments/Updates
6.12 Skystar Bio-pharm
6.12.1 Skystar Bio-pharm Company Information
6.12.2 Skystar Bio-pharm Description and Business Overview
6.12.3 Skystar Bio-pharm Coccidiosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Skystar Bio-pharm Coccidiosis Vaccines Product Portfolio
6.12.5 Skystar Bio-pharm Recent Developments/Updates
6.13 Hlinte
6.13.1 Hlinte Company Information
6.13.2 Hlinte Description and Business Overview
6.13.3 Hlinte Coccidiosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hlinte Coccidiosis Vaccines Product Portfolio
6.13.5 Hlinte Recent Developments/Updates
6.14 Guangdong Winsun Bio-pharmaceutical
6.14.1 Guangdong Winsun Bio-pharmaceutical Company Information
6.14.2 Guangdong Winsun Bio-pharmaceutical Description and Business Overview
6.14.3 Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Product Portfolio
6.14.5 Guangdong Winsun Bio-pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Coccidiosis Vaccines Industry Chain Analysis
7.2 Coccidiosis Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Coccidiosis Vaccines Production Mode & Process
7.4 Coccidiosis Vaccines Sales and Marketing
7.4.1 Coccidiosis Vaccines Sales Channels
7.4.2 Coccidiosis Vaccines Distributors
7.5 Coccidiosis Vaccines Customers
8 Coccidiosis Vaccines Market Dynamics
8.1 Coccidiosis Vaccines Industry Trends
8.2 Coccidiosis Vaccines Market Drivers
8.3 Coccidiosis Vaccines Market Challenges
8.4 Coccidiosis Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
MSD Animal Health
Boehringer Ingelheim
Hipra
Bioproperties Pty Ltd
Huvepharma
Nisseiken Co., Ltd.
Biopharm GmbH
Ceva Santé Animale
Vaxxinova
Foshan Standard Biotech
Qilu Qingda Bio-Pharmaceutical
Skystar Bio-Pharm
Hlinte
Guangdong Winsun Bio Pharmaceutical
List of Tables
 Table 1. Global Coccidiosis Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Coccidiosis Vaccines Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Coccidiosis Vaccines Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Coccidiosis Vaccines Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Coccidiosis Vaccines Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Coccidiosis Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Coccidiosis Vaccines Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Coccidiosis Vaccines Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Coccidiosis Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Coccidiosis Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Coccidiosis Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Coccidiosis Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Coccidiosis Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coccidiosis Vaccines as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Coccidiosis Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Coccidiosis Vaccines Sales by Region (2019-2024) & (K Units)
 Table 18. Global Coccidiosis Vaccines Sales Market Share by Region (2019-2024)
 Table 19. Global Coccidiosis Vaccines Sales by Region (2025-2030) & (K Units)
 Table 20. Global Coccidiosis Vaccines Sales Market Share by Region (2025-2030)
 Table 21. Global Coccidiosis Vaccines Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Coccidiosis Vaccines Revenue Market Share by Region (2019-2024)
 Table 23. Global Coccidiosis Vaccines Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Coccidiosis Vaccines Revenue Market Share by Region (2025-2030)
 Table 25. North America Coccidiosis Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Coccidiosis Vaccines Sales by Country (2019-2024) & (K Units)
 Table 27. North America Coccidiosis Vaccines Sales by Country (2025-2030) & (K Units)
 Table 28. North America Coccidiosis Vaccines Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Coccidiosis Vaccines Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Coccidiosis Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Coccidiosis Vaccines Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Coccidiosis Vaccines Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Coccidiosis Vaccines Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Coccidiosis Vaccines Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Coccidiosis Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Coccidiosis Vaccines Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Coccidiosis Vaccines Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Coccidiosis Vaccines Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Coccidiosis Vaccines Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Coccidiosis Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Coccidiosis Vaccines Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Coccidiosis Vaccines Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Coccidiosis Vaccines Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Coccidiosis Vaccines Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Coccidiosis Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Coccidiosis Vaccines Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Coccidiosis Vaccines Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Coccidiosis Vaccines Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Coccidiosis Vaccines Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Coccidiosis Vaccines Sales (K Units) by Type (2019-2024)
 Table 51. Global Coccidiosis Vaccines Sales (K Units) by Type (2025-2030)
 Table 52. Global Coccidiosis Vaccines Sales Market Share by Type (2019-2024)
 Table 53. Global Coccidiosis Vaccines Sales Market Share by Type (2025-2030)
 Table 54. Global Coccidiosis Vaccines Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Coccidiosis Vaccines Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Coccidiosis Vaccines Revenue Market Share by Type (2019-2024)
 Table 57. Global Coccidiosis Vaccines Revenue Market Share by Type (2025-2030)
 Table 58. Global Coccidiosis Vaccines Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Coccidiosis Vaccines Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Coccidiosis Vaccines Sales (K Units) by Application (2019-2024)
 Table 61. Global Coccidiosis Vaccines Sales (K Units) by Application (2025-2030)
 Table 62. Global Coccidiosis Vaccines Sales Market Share by Application (2019-2024)
 Table 63. Global Coccidiosis Vaccines Sales Market Share by Application (2025-2030)
 Table 64. Global Coccidiosis Vaccines Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Coccidiosis Vaccines Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Coccidiosis Vaccines Revenue Market Share by Application (2019-2024)
 Table 67. Global Coccidiosis Vaccines Revenue Market Share by Application (2025-2030)
 Table 68. Global Coccidiosis Vaccines Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Coccidiosis Vaccines Price (US$/Unit) by Application (2025-2030)
 Table 70. MSD Animal Health Company Information
 Table 71. MSD Animal Health Description and Business Overview
 Table 72. MSD Animal Health Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. MSD Animal Health Coccidiosis Vaccines Product
 Table 74. MSD Animal Health Recent Developments/Updates
 Table 75. Boehringer Ingelheim Company Information
 Table 76. Boehringer Ingelheim Description and Business Overview
 Table 77. Boehringer Ingelheim Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Boehringer Ingelheim Coccidiosis Vaccines Product
 Table 79. Boehringer Ingelheim Recent Developments/Updates
 Table 80. HIPRA Company Information
 Table 81. HIPRA Description and Business Overview
 Table 82. HIPRA Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. HIPRA Coccidiosis Vaccines Product
 Table 84. HIPRA Recent Developments/Updates
 Table 85. Bioproperties Company Information
 Table 86. Bioproperties Description and Business Overview
 Table 87. Bioproperties Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Bioproperties Coccidiosis Vaccines Product
 Table 89. Bioproperties Recent Developments/Updates
 Table 90. Huvepharma Company Information
 Table 91. Huvepharma Description and Business Overview
 Table 92. Huvepharma Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Huvepharma Coccidiosis Vaccines Product
 Table 94. Huvepharma Recent Developments/Updates
 Table 95. Nisseiken Company Information
 Table 96. Nisseiken Description and Business Overview
 Table 97. Nisseiken Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Nisseiken Coccidiosis Vaccines Product
 Table 99. Nisseiken Recent Developments/Updates
 Table 100. Biopharm Company Information
 Table 101. Biopharm Description and Business Overview
 Table 102. Biopharm Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Biopharm Coccidiosis Vaccines Product
 Table 104. Biopharm Recent Developments/Updates
 Table 105. Ceva Santé Animale Company Information
 Table 106. Ceva Santé Animale Description and Business Overview
 Table 107. Ceva Santé Animale Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Ceva Santé Animale Coccidiosis Vaccines Product
 Table 109. Ceva Santé Animale Recent Developments/Updates
 Table 110. Vaxxinova Company Information
 Table 111. Vaxxinova Description and Business Overview
 Table 112. Vaxxinova Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Vaxxinova Coccidiosis Vaccines Product
 Table 114. Vaxxinova Recent Developments/Updates
 Table 115. Foshan Standard Biotech Company Information
 Table 116. Foshan Standard Biotech Description and Business Overview
 Table 117. Foshan Standard Biotech Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Foshan Standard Biotech Coccidiosis Vaccines Product
 Table 119. Foshan Standard Biotech Recent Developments/Updates
 Table 120. Qilu Qingda Bio-Pharmaceutical Company Information
 Table 121. Qilu Qingda Bio-Pharmaceutical Description and Business Overview
 Table 122. Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines Product
 Table 124. Qilu Qingda Bio-Pharmaceutical Recent Developments/Updates
 Table 125. Skystar Bio-pharm Company Information
 Table 126. Skystar Bio-pharm Description and Business Overview
 Table 127. Skystar Bio-pharm Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Skystar Bio-pharm Coccidiosis Vaccines Product
 Table 129. Skystar Bio-pharm Recent Developments/Updates
 Table 130. Hlinte Company Information
 Table 131. Hlinte Description and Business Overview
 Table 132. Hlinte Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Hlinte Coccidiosis Vaccines Product
 Table 134. Hlinte Recent Developments/Updates
 Table 135. Guangdong Winsun Bio-pharmaceutical Company Information
 Table 136. Guangdong Winsun Bio-pharmaceutical Description and Business Overview
 Table 137. Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines Product
 Table 139. Guangdong Winsun Bio-pharmaceutical Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Coccidiosis Vaccines Distributors List
 Table 143. Coccidiosis Vaccines Customers List
 Table 144. Coccidiosis Vaccines Market Trends
 Table 145. Coccidiosis Vaccines Market Drivers
 Table 146. Coccidiosis Vaccines Market Challenges
 Table 147. Coccidiosis Vaccines Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Coccidiosis Vaccines
 Figure 2. Global Coccidiosis Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Coccidiosis Vaccines Market Share by Type: 2023 & 2030
 Figure 4. Attenuated Vaccines Product Picture
 Figure 5. Non-attenuated Vaccines Product Picture
 Figure 6. Global Coccidiosis Vaccines Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Coccidiosis Vaccines Market Share by Application: 2023 & 2030
 Figure 8. Poultry
 Figure 9. Rabbit
 Figure 10. Others
 Figure 11. Global Coccidiosis Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Coccidiosis Vaccines Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Coccidiosis Vaccines Sales (2019-2030) & (K Units)
 Figure 14. Global Coccidiosis Vaccines Average Price (US$/Unit) & (2019-2030)
 Figure 15. Coccidiosis Vaccines Report Years Considered
 Figure 16. Coccidiosis Vaccines Sales Share by Manufacturers in 2023
 Figure 17. Global Coccidiosis Vaccines Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Coccidiosis Vaccines Players: Market Share by Revenue in Coccidiosis Vaccines in 2023
 Figure 19. Coccidiosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Coccidiosis Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Coccidiosis Vaccines Sales Market Share by Country (2019-2030)
 Figure 22. North America Coccidiosis Vaccines Revenue Market Share by Country (2019-2030)
 Figure 23. United States Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Coccidiosis Vaccines Sales Market Share by Country (2019-2030)
 Figure 26. Europe Coccidiosis Vaccines Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Coccidiosis Vaccines Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Coccidiosis Vaccines Revenue Market Share by Region (2019-2030)
 Figure 34. China Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Coccidiosis Vaccines Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Coccidiosis Vaccines Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Coccidiosis Vaccines Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Coccidiosis Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Coccidiosis Vaccines by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Coccidiosis Vaccines by Type (2019-2030)
 Figure 53. Global Coccidiosis Vaccines Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Coccidiosis Vaccines by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Coccidiosis Vaccines by Application (2019-2030)
 Figure 56. Global Coccidiosis Vaccines Price (US$/Unit) by Application (2019-2030)
 Figure 57. Coccidiosis Vaccines Value Chain
 Figure 58. Coccidiosis Vaccines Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Poultry Coccidiosis Vaccines Market Research Report 2025
Global Coccidiosis Vaccines in Chickens Market Research Report 2024
Global Coccidia Virus Live Vaccine Market Research Report 2025
Global Coccidiosis Vaccine for Chickens Market Research Report 2024
Global Coccidiosis Treatment Market Research Report 2024
Global Coccidiosis Treatment Solution Market Research Report 2024
Global Anticoccidial Solutions Market Research Report 2024
Coccidiostat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poultry Biological Products and Poultry Vaccines Market Research Report 2024
Global Veterinary Biological Vaccines Market Research Report 2025
Veterinary Vaccine Market
Global Chicken Marek s Disease Live Vaccine Market Research Report 2024
Global Poultry and Livestock Vaccines Market Research Report 2025
Global Marek s Disease Vaccine Market Research Report 2024
Global Poultry Vaccines Market Research Report 2025
Global Poultry Live Vaccines Market Research Report 2025
Global Poultry Live Attenuated Vaccine Market Research Report 2024
Global Poultry Killed Vaccines Market Research Report 2025
Feed Anticoccidials for Ruminants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Livestock Vaccines and Poultry Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions